MiMedx Group, Inc. Asset Retirement Obligation, Accretion Expense
MiMedx Group, Inc. (MDXG) reported Asset Retirement Obligation, Accretion Expense of $24.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AssetRetirementObligationAccretionExpense · last filed 2025-04-30
- MiMedx Group, Inc. asset retirement obligation, accretion expense for the quarter ending 2025-03-31 was $24.00K, a 9.09% increase year-over-year.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for the quarter ending 2024-03-31 was $22.00K, a 0.00% change year-over-year.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for the quarter ending 2023-12-31 was $23.00K, a 0.00% change year-over-year.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for the quarter ending 2023-09-30 was $27.00K, a 17.39% increase year-over-year.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for fiscal 2023 was $93.00K, a 1.09% increase from fiscal 2022.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for fiscal 2022 was $92.00K, a 13.58% increase from fiscal 2021.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for fiscal 2021 was $81.00K, a 710.00% increase from fiscal 2020.
- MiMedx Group, Inc. asset retirement obligation, accretion expense for fiscal 2020 was $10.00K.
| Period end | Asset Retirement Obligation, Accretion Expense 3 month | Asset Retirement Obligation, Accretion Expense 6 month | Asset Retirement Obligation, Accretion Expense 9 month | Asset Retirement Obligation, Accretion Expense 12 month |
|---|---|---|---|---|
| 2025-03-31 | $24.00K 10-Q · filed 2025-04-30 | |||
| 2024-03-31 | $22.00K 10-Q · filed 2025-04-30 | $45.00K derived: sum of 2 quarters · filed 2025-04-30 | $72.00K derived: sum of 3 quarters · filed 2025-04-30 | $93.00K derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $50.00K derived: sum of 2 quarters · filed 2024-02-28 | $71.00K derived: sum of 3 quarters · filed 2024-02-28 | $93.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $48.00K derived: sum of 2 quarters · filed 2023-10-30 | $70.00K 10-Q · filed 2023-10-30 | $93.00K derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $43.00K 10-Q · filed 2023-08-01 | $66.00K derived: sum of 3 quarters · filed 2024-04-30 | $89.00K derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-03-31 | $22.00K 10-Q · filed 2024-04-30 | $45.00K derived: sum of 2 quarters · filed 2024-04-30 | $68.00K derived: sum of 3 quarters · filed 2024-04-30 | $92.00K derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $46.00K derived: sum of 2 quarters · filed 2024-02-28 | $70.00K derived: sum of 3 quarters · filed 2024-02-28 | $92.00K 10-K · filed 2024-02-28 |
| 2022-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $47.00K derived: sum of 2 quarters · filed 2023-10-30 | $69.00K 10-Q · filed 2023-10-30 | $93.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $46.00K 10-Q · filed 2023-08-01 | $70.00K derived: sum of 3 quarters · filed 2024-02-28 | $90.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $22.00K 10-Q · filed 2023-05-02 | $46.00K derived: sum of 2 quarters · filed 2024-02-28 | $66.00K derived: sum of 3 quarters · filed 2024-02-28 | $86.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $44.00K derived: sum of 2 quarters · filed 2024-02-28 | $64.00K derived: sum of 3 quarters · filed 2024-02-28 | $81.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $40.00K derived: sum of 2 quarters · filed 2022-11-02 | $57.00K 10-Q · filed 2022-11-02 | $67.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $37.00K 10-Q · filed 2022-08-02 | $47.00K derived: sum of 3 quarters · filed 2023-02-28 | $47.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-03 | $27.00K derived: sum of 2 quarters · filed 2023-02-28 | $27.00K derived: sum of 3 quarters · filed 2023-02-28 | $27.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $10.00K derived: sum of 2 quarters · filed 2023-02-28 | $10.00K derived: sum of 3 quarters · filed 2023-02-28 | $10.00K 10-K · filed 2023-02-28 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-28 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-28 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |